A 3D Model of Human Buccal Mucosa for Compatibility Testing of Mouth Rinsing Solutions

Oral mucositis is the most common and severe non-hematological complication associated with cancer radiotherapy, chemotherapy, or their combination. Treatment of oral mucositis focuses on pain management and the use of natural anti-inflammatory, sometimes weakly antiseptic mouth rinses in combination with optimal oral cavity hygiene. To prevent negative effects of rinsing, accurate testing of oral care products is necessary. Due to their ability to mimic realistic in-vivo conditions, 3D models may be an appropriate option in compatibility testing of anti-inflammatory and antiseptically effective mouth rinses. We present a 3D model of oral mucosa based on the cell line TR-146 with a physical barrier, characterized by high transepithelial electrical resistance (TEER) and confirmed cell integrity. Histological characterization of the 3D mucosa model showed a stratified, non-keratinized multilayer of epithelial cells similar to that of human oral mucosa. By means of immuno-staining, tissue-specific expression of cytokeratin 13 and 14 was shown. Incubation of the 3D mucosa model with the rinses had no effects on cell viability, but TEER decreased 24h after incubation in all solutions except ProntOral (R). Analogous to skin models, the established 3D model meets the quality control criteria of OECD guidelines and may therefore be suitable for comparing the cytocompatibility of oral rinses.

Automated summary

Oral mucositis is a common and severe complication of cancer radiotherapy and chemotherapy, and its treatment requires pain management and the use of natural anti-inflammatory mouth rinses with good oral hygiene. Testing of oral care products is crucial to prevent negative effects. A 3D model of oral mucosa based on the TR-146 cell line has been developed, with similar characteristics to human oral mucosa, making it suitable for evaluating the compatibility of mouth rinses.